Cargando…

Detection of Early Myocardial Dysfunction by Imaging Biomarkers in Cancer Patients Undergoing Photon Beam vs. Proton Beam Radiotherapy: A Prospective Study

1. Background: We sought to determine acute and subacute changes in cardiac function after proton beam (PBT) and photon beam (PhT) radiotherapy (RT) using conventional and two-dimensional speckle tracking echocardiography (2D-STE) in patients with malignant breast and thoracic tumors. 2. Methods: Be...

Descripción completa

Detalles Bibliográficos
Autores principales: Abbasi, Muhannad Aboud, Bruno, Giulia, Di Stefano, Cristina, Garcia Bello, Laura, Laack, Nadia N., Corbin, Kimberly S., Whitaker, Thomas J., Pellikka, Patricia A., Mutter, Robert W., Villarraga, Hector R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607871/
https://www.ncbi.nlm.nih.gov/pubmed/37887865
http://dx.doi.org/10.3390/jcdd10100418
_version_ 1785127645406560256
author Abbasi, Muhannad Aboud
Bruno, Giulia
Di Stefano, Cristina
Garcia Bello, Laura
Laack, Nadia N.
Corbin, Kimberly S.
Whitaker, Thomas J.
Pellikka, Patricia A.
Mutter, Robert W.
Villarraga, Hector R.
author_facet Abbasi, Muhannad Aboud
Bruno, Giulia
Di Stefano, Cristina
Garcia Bello, Laura
Laack, Nadia N.
Corbin, Kimberly S.
Whitaker, Thomas J.
Pellikka, Patricia A.
Mutter, Robert W.
Villarraga, Hector R.
author_sort Abbasi, Muhannad Aboud
collection PubMed
description 1. Background: We sought to determine acute and subacute changes in cardiac function after proton beam (PBT) and photon beam (PhT) radiotherapy (RT) using conventional and two-dimensional speckle tracking echocardiography (2D-STE) in patients with malignant breast and thoracic tumors. 2. Methods: Between March 2016 and March 2017, 70 patients with breast or thoracic cancer were prospectively enrolled and underwent transthoracic echocardiography with comprehensive strain analysis at pretreatment, mid-treatment, end of treatment, and 3 months after RT. 3. Results: PBT was used to treat 44 patients; PhT 26 patients. Mean ± SD age was 55 ± 12 years; most patients (93%) were women. The median (interquartile range) of the mean heart dose was lower in the PBT than the PhT group (47 [27–79] vs. 217 [120–596] cGy, respectively; p < 0.001). Ejection fraction did not change in either group. Only the PhT group had reduced systolic tissue Doppler velocities at 3 months. 2D-STE showed changes in endocardial and epicardial longitudinal, radial, and circumferential early diastolic strain rate (SRe) in patients undergoing PhT (global longitudinal SRe, pretreatment vs. end of treatment (p = 0.04); global circumferential SRe, pretreatment vs. at 3-month follow-up (p = 0.003); global radial SRe, pretreatment vs. at 3-month follow-up (p = 0.02) for endocardial values). Epicardial strain values decreased significantly only in patients treated with PhT. Patients in the PhT group had a significant decrease in epicardial global longitudinal systolic strain rate (GLSRs) (epicardial GLSRs, at baseline vs. at end of treatment [p = 0.009]) and in GCSRe and GRSRe (epicardial GCSRe, at baseline vs. at 3-month follow-up (p = 0.02); epicardial GRSRe, at baseline vs. at 3-month follow-up (p = 0.03)) during treatment and follow-up. No changes on 2D-STE were detected in the PBT group. 4. Conclusions: Patients who underwent PhT but not PBT had reduced tissue Doppler velocities and SRe values during follow-up, suggesting early myocardial relaxation abnormalities. PBT shows promise as a cardiac-sparing RT technology.
format Online
Article
Text
id pubmed-10607871
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-106078712023-10-28 Detection of Early Myocardial Dysfunction by Imaging Biomarkers in Cancer Patients Undergoing Photon Beam vs. Proton Beam Radiotherapy: A Prospective Study Abbasi, Muhannad Aboud Bruno, Giulia Di Stefano, Cristina Garcia Bello, Laura Laack, Nadia N. Corbin, Kimberly S. Whitaker, Thomas J. Pellikka, Patricia A. Mutter, Robert W. Villarraga, Hector R. J Cardiovasc Dev Dis Article 1. Background: We sought to determine acute and subacute changes in cardiac function after proton beam (PBT) and photon beam (PhT) radiotherapy (RT) using conventional and two-dimensional speckle tracking echocardiography (2D-STE) in patients with malignant breast and thoracic tumors. 2. Methods: Between March 2016 and March 2017, 70 patients with breast or thoracic cancer were prospectively enrolled and underwent transthoracic echocardiography with comprehensive strain analysis at pretreatment, mid-treatment, end of treatment, and 3 months after RT. 3. Results: PBT was used to treat 44 patients; PhT 26 patients. Mean ± SD age was 55 ± 12 years; most patients (93%) were women. The median (interquartile range) of the mean heart dose was lower in the PBT than the PhT group (47 [27–79] vs. 217 [120–596] cGy, respectively; p < 0.001). Ejection fraction did not change in either group. Only the PhT group had reduced systolic tissue Doppler velocities at 3 months. 2D-STE showed changes in endocardial and epicardial longitudinal, radial, and circumferential early diastolic strain rate (SRe) in patients undergoing PhT (global longitudinal SRe, pretreatment vs. end of treatment (p = 0.04); global circumferential SRe, pretreatment vs. at 3-month follow-up (p = 0.003); global radial SRe, pretreatment vs. at 3-month follow-up (p = 0.02) for endocardial values). Epicardial strain values decreased significantly only in patients treated with PhT. Patients in the PhT group had a significant decrease in epicardial global longitudinal systolic strain rate (GLSRs) (epicardial GLSRs, at baseline vs. at end of treatment [p = 0.009]) and in GCSRe and GRSRe (epicardial GCSRe, at baseline vs. at 3-month follow-up (p = 0.02); epicardial GRSRe, at baseline vs. at 3-month follow-up (p = 0.03)) during treatment and follow-up. No changes on 2D-STE were detected in the PBT group. 4. Conclusions: Patients who underwent PhT but not PBT had reduced tissue Doppler velocities and SRe values during follow-up, suggesting early myocardial relaxation abnormalities. PBT shows promise as a cardiac-sparing RT technology. MDPI 2023-10-04 /pmc/articles/PMC10607871/ /pubmed/37887865 http://dx.doi.org/10.3390/jcdd10100418 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Abbasi, Muhannad Aboud
Bruno, Giulia
Di Stefano, Cristina
Garcia Bello, Laura
Laack, Nadia N.
Corbin, Kimberly S.
Whitaker, Thomas J.
Pellikka, Patricia A.
Mutter, Robert W.
Villarraga, Hector R.
Detection of Early Myocardial Dysfunction by Imaging Biomarkers in Cancer Patients Undergoing Photon Beam vs. Proton Beam Radiotherapy: A Prospective Study
title Detection of Early Myocardial Dysfunction by Imaging Biomarkers in Cancer Patients Undergoing Photon Beam vs. Proton Beam Radiotherapy: A Prospective Study
title_full Detection of Early Myocardial Dysfunction by Imaging Biomarkers in Cancer Patients Undergoing Photon Beam vs. Proton Beam Radiotherapy: A Prospective Study
title_fullStr Detection of Early Myocardial Dysfunction by Imaging Biomarkers in Cancer Patients Undergoing Photon Beam vs. Proton Beam Radiotherapy: A Prospective Study
title_full_unstemmed Detection of Early Myocardial Dysfunction by Imaging Biomarkers in Cancer Patients Undergoing Photon Beam vs. Proton Beam Radiotherapy: A Prospective Study
title_short Detection of Early Myocardial Dysfunction by Imaging Biomarkers in Cancer Patients Undergoing Photon Beam vs. Proton Beam Radiotherapy: A Prospective Study
title_sort detection of early myocardial dysfunction by imaging biomarkers in cancer patients undergoing photon beam vs. proton beam radiotherapy: a prospective study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607871/
https://www.ncbi.nlm.nih.gov/pubmed/37887865
http://dx.doi.org/10.3390/jcdd10100418
work_keys_str_mv AT abbasimuhannadaboud detectionofearlymyocardialdysfunctionbyimagingbiomarkersincancerpatientsundergoingphotonbeamvsprotonbeamradiotherapyaprospectivestudy
AT brunogiulia detectionofearlymyocardialdysfunctionbyimagingbiomarkersincancerpatientsundergoingphotonbeamvsprotonbeamradiotherapyaprospectivestudy
AT distefanocristina detectionofearlymyocardialdysfunctionbyimagingbiomarkersincancerpatientsundergoingphotonbeamvsprotonbeamradiotherapyaprospectivestudy
AT garciabellolaura detectionofearlymyocardialdysfunctionbyimagingbiomarkersincancerpatientsundergoingphotonbeamvsprotonbeamradiotherapyaprospectivestudy
AT laacknadian detectionofearlymyocardialdysfunctionbyimagingbiomarkersincancerpatientsundergoingphotonbeamvsprotonbeamradiotherapyaprospectivestudy
AT corbinkimberlys detectionofearlymyocardialdysfunctionbyimagingbiomarkersincancerpatientsundergoingphotonbeamvsprotonbeamradiotherapyaprospectivestudy
AT whitakerthomasj detectionofearlymyocardialdysfunctionbyimagingbiomarkersincancerpatientsundergoingphotonbeamvsprotonbeamradiotherapyaprospectivestudy
AT pellikkapatriciaa detectionofearlymyocardialdysfunctionbyimagingbiomarkersincancerpatientsundergoingphotonbeamvsprotonbeamradiotherapyaprospectivestudy
AT mutterrobertw detectionofearlymyocardialdysfunctionbyimagingbiomarkersincancerpatientsundergoingphotonbeamvsprotonbeamradiotherapyaprospectivestudy
AT villarragahectorr detectionofearlymyocardialdysfunctionbyimagingbiomarkersincancerpatientsundergoingphotonbeamvsprotonbeamradiotherapyaprospectivestudy